Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

  • This share is currently suspended. It was suspended at a price of 81.80
  • There is currently no data for RNO

AGM Statement

20 Jul 2016 07:00

RNS Number : 6661E
Renold PLC
20 July 2016
 

Renold plc

("Renold", "the Company" or "the Group")

 

AGM Statement

 

Renold, a leading international supplier of industrial chains and related power transmission products, is today issuing, ahead of its Annual General Meeting to be held at 11:00am, the following statement in respect of the first quarter of the financial year ending 31 March 2017 ('the Quarter').

 

The Quarter saw overall Group performance in line with expectations. Order intake improvements support the Board's stated expectation of an end to sales declines from the second half of this financial year. As expected, underlying (1) sales in the Quarter were down 9.6% which represents a recovering trend, especially in Chain, from the 11% fall in the second half of the prior year.

 

Underlying Group order intake was 3.1% better than the same period in the prior year with Chain 3.1% ahead and Torque Transmission 3.3% ahead. In Chain, Europe, Australasia and China all delivered growth in underlying order intake. The Americas fell primarily as a result of distributor de-stocking. The trend, however, is an improving one with the fall in the Americas' order intake lower than the previous three quarters. The book to bill ratio for the Group in the Quarter was 110% compared to 96% in the first quarter of the prior year. Underlying orders were £4.0m above underlying sales. In Chain the Book to Bill ratio was 108% (99% in the prior year) and in Torque Transmission 119% (88% in the prior year).

 

It will take time for the full economic and currency implications of the Brexit vote to become clear. However, almost 40% of the Group's external sales are made in the Americas, just under 20% in the continental EU countries and only 8% in the UK. The Group has also not experienced any adverse impact from distributor de-stocking in Europe in the Quarter which had been a feature of the second half of the prior year.

 

The Group continues to implement STEP 2020 strategic initiatives and to invest in new capital equipment. In addition, the integration of the acquired Tooth Chain business continues to proceed smoothly and the business has generated modest growth in order intake and sales compared to the same period prior to the acquisition by Renold.

 

Improving order intake supports an improving outlook for sales in the second half. Continued delivery of STEP 2020 initiatives will add further support to the Group's results. The outlook for the first half and the full year adjusted (2) operating profit therefore remain in line with the Board's expectations.

 

Robert Purcell, Chief Executive of Renold, said:

"Uncertainty and volatility in external markets have been met with the continued delivery of our STEP 2020 Strategic Plan. The Chain division is seeing welcome early signs of lower volatility. The strong growth in Torque Transmission order intake in the period points to an improved outlook for the second half.

 

We continue to invest in growth related activities focussed on expanding our sales foot print and new product development. Multiple initiatives are also underway, focussed on efficiency gains and our cost base to improve further our operational gearing. STEP 2020 remains a robust platform to deliver our goal of mid-teens operating margins."

 

20 July 2016

 

 

 

(1) The use of "underlying" excludes the impact of changes in foreign exchange rates by retranslating the prior year comparative figures to the current year exchange rate.

 (2) Adjusted items exclude exceptional items, the costs of administering closed defined benefit pension schemes, the amortization of acquired intangibles and any associated tax thereon.

 

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

 

Brian Tenner, Finance Director

 

 

 

Arden Partners

020 7614 5917

Chris Hardie

 

 

 

 

 

Instinctif Partners

020 7457 2020

Mark Garraway

 

Helen Tarbet

 

 

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSFAFUUFMSESW
Date   Source Headline
16th Apr 20151:58 pmRNSHolding(s) in Company
13th Apr 201511:22 amRNSHolding(s) in Company
9th Apr 20157:00 amRNSTrading Update
2nd Feb 201511:49 amRNSBLOCK LISTING SIX MONTHLY RETURN
25th Nov 20147:00 amRNSHalf Yearly Report
30th Oct 201410:05 amRNSDirector Declaration
13th Oct 20147:00 amRNSTrading Update
4th Sep 201410:36 amRNSHolding(s) in Company
15th Aug 20143:21 pmRNSDirector/PDMR Shareholding
14th Aug 201410:21 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Aug 201410:20 amRNSBLOCK LISTING SIX MONTHLY RETURN
5th Aug 20149:48 amRNSDirector/PDMR Shareholding
22nd Jul 20142:17 pmRNSResult of AGM
22nd Jul 20147:00 amRNSAGM Statement and Interim Management Statement
11th Jul 20144:25 pmRNSHolding(s) in Company - Replacement
10th Jul 20144:01 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
20th Jun 201410:39 amRNSAnnual Report and Accounts
5th Jun 20143:54 pmRNSGRANT OF AWARDS - PERFORMANCE SHARE PLAN
27th May 20147:00 amRNSFinal Results
8th Apr 20147:00 amRNSTrading Update
13th Feb 20147:00 amRNSInterim Management Statement
22nd Nov 201310:37 amRNSHolding(s) in Company
19th Nov 20137:00 amRNSHalf Yearly Report
23rd Oct 20138:41 amRNSDirector Declaration
22nd Oct 20137:00 amRNSStrategic Review and Period End Trading Update
30th Sep 201310:49 amRNSHolding(s) in Company
30th Sep 201310:47 amRNSHolding(s) in Company
20th Sep 20132:58 pmRNSBlocklisting Interim Review
20th Sep 20132:56 pmRNSBlocklisting Interim Review
30th Aug 20139:00 amRNSDirector/PDMR Shareholding
28th Aug 20133:27 pmRNSDirector/PDMR Shareholding
27th Aug 201310:00 amRNSStrategic Review Update
22nd Aug 20132:33 pmRNSIssue of Equity
13th Aug 20132:00 pmRNSIssue of Equity
25th Jul 20134:23 pmRNSGrant of awards
24th Jul 20131:08 pmRNSResult of AGM
23rd Jul 20137:00 amRNSAGM Statement and Interim Management Statement
8th Jul 20137:00 amRNSMerger of the UK defined benefit pensions schemes
5th Jul 20134:13 pmRNSHolding(s) in Company
4th Jul 20134:35 pmRNSPrice Monitoring Extension
1st Jul 201310:20 amRNSHolding(s) in Company
21st Jun 201312:14 pmRNSRe. Annual Report and Accounts
18th Jun 201310:21 amRNSHolding(s) in Company
17th Jun 201311:32 amRNSHolding(s) in Company
17th Jun 201310:54 amRNSDirector/PDMR Shareholding
3rd Jun 20134:35 pmRNSPrice Monitoring Extension
3rd Jun 20132:15 pmRNSDirector/PDMR Shareholding
28th May 20137:00 amRNSFinal Results
23rd May 20131:27 pmRNSHolding(s) in Company
9th May 20139:39 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.